Marpai, Inc.
Other OTCCapital Structure
•
in mil. unless spec.Working Capital
•
in mil. unless spec.Growth Rates
•
in mil. unless spec.Quarterly Revenue
•
in mil. unless spec.Quarterly Earnings Per Share
•
in mil. unless spec.Quarterly Dividends Per Share
•
in mil. unless spec.- CEO
- Damien Francis Lamendola
- Full Time Employees
- 117
- Sector
- Healthcare
- Industry
- Medical - Healthcare Plans
- Address
- 401 Park Avenue South New York City NY United States of America 10016
- IPO Date
- Oct 27, 2021
- CIK
- 0001844392
- Website
- marpaihealth.com
- Similar Companies
- Business
- Marpai, Inc. operates as a technology-driven healthcare payer company specializing in third-party administration (TPA) and value-oriented health plan services primarily for self-funded employer health plans in the United States. Founded in 2021 and headquartered in Tampa, Florida, Marpai offers an AI-powered platform that integrates TPA, pharmacy benefit management (PBM), care management, case management, actuarial services, bill review, and cost containment solutions. The company focuses on serving self-insured employers directly paying for employee health benefits, leveraging advanced data analytics to reduce health plan costs and improve member health outcomes. Marpai’s core products and services include third-party administration services for self-funded health plans; pharmacy benefit management; care and case management; actuarial and billing review services; cost containment solutions; and access to leading provider networks such as Aetna and Cigna. It operates nationally across the U.S. and also serves markets in Israel, competing in the $22 billion TPA sector representing over $1.5 trillion in annual medical claims. Recent major company developments include a key renewal of its network access agreement with Aetna's Signature Administrator PPO network, ensuring continued broad access and competitive provider discounts for its clients. Marpai has demonstrated a robust sales cycle for 2026, securing new client volume exceeding internal expectations, signaling scalable growth and progress toward profitability targets expected by 2025. The company continues its operational turnaround with a new leadership team focused on revenue growth and cost reduction, improved AI algorithms that accelerate cost savings, and expansion of its technology platform aimed at making healthcare more proactive, transparent, and efficient. Marpai serves a large addressable market encompassing approximately 165 million Americans covered under employer health plans, with 64% of those being self-funded. It positions itself as a transformative player in an otherwise low-tech traditional TPA industry by deploying advanced artificial intelligence to optimize health plan administration and reduce total healthcare spending for employers. Overall, Marpai combines technology, data analytics, and comprehensive administrative services to modernize third-party administration for self-funded employer health plans, operating mainly in the United States with headquarters in Tampa, Florida, since its incorporation in 2021. Its recent strategic partnerships, technology enhancements, and sales momentum position it for continued growth and operational improvement in the competitive healthcare payer sector.
Marpai Inc. Announces Unprecedented Growth with 192,000 New Estimated Member Lives Across TPA and MarpaiRx PBM Platforms; Expects to Achieve Positive Cash Flow and EBITDA Beginning August 2026
MARPAI REPORTS FIRST QUARTER 2026 FINANCIAL RESULTS
Marpai, Inc. Announces Significant New Business Wins across TPA and MarpaiRx; Solidifies Forecast for Profitability
Marpai, Inc. Secures Major Strategic Marketing Collaboration to Continue Acceleration of MarpaiRx Growth Nationwide
Marpai Secures Access to Network Creating Major Growth Catalyst for MarpaiRx Representing Up to 1.5 million Covered Lives
Marpai, Inc. Secures Major Strategic Wins for MarpaiRx, Adding Over 19,000 Lives and Accelerating High-Growth Platform Expansion
MARPAI, INC. HIRES PHARMACY EXECUTIVE MIMI DAVIS AS PRESIDENT OF MARPAIRX TO DRIVE STRATEGIC GROWTH
MARPAI ANNOUNCES 2026 MOMENTUM AND KEY PARTNERSHIP EXPANSION
Marpai, Inc. (MRAI) Q3 2025 Earnings Call Transcript
MARPAI REPORTS THIRD QUARTER 2025 FINANCIAL RESULTS
MARPAI TO HOST WEBCAST ON NOVEMBER 13, 2025 TO DISCUSS THIRD QUARTER 2025 FINANCIAL RESULTS
MARPAI RECOGNIZED AS 2025 TOP THIRD PARTY ADMINISTRATOR
MARPAI, INC. RECEIVES ADDITIONAL $200,000 INVESTMENT FROM DAMIEN LAMENDOLA'S HILLCOUR INVESTMENT FUND
Marpai, Inc. (MRAI) Q2 2025 Earnings Call Transcript
MARPAI REPORTS SECOND QUARTER 2025 FINANCIAL RESULTS
MARPAI TO HOST WEBCAST ON AUGUST 14, 2025 TO DISCUSS SECOND QUARTER 2025 FINANCIAL RESULTS
MARPAIRX REVOLUTIONIZES PHARMACY BENEFITS WITH UNPRECEDENTED TRANSPARENCY AND SAVINGS
Marpai, Inc. (MRAI) Q1 2025 Earnings Call Transcript
MARPAI REPORTS FIRST QUARTER 2025 FINANCIAL RESULTS
MARPAI HIRES DALLAS SCRIP AS CHIEF OPERATING OFFICER